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SUMMARY 
In 34 patients of endogenous depression and 30 normal controls, the dexamethasone suppression test (DST) 
had a sensitivity of 67.6%, a specificity of 93.3% and a positive predictive power of 92%, which compares favourably 
with other diagnostic tests in clinical medicine. DST nonsuppressors were significantly more depressed as compared 
to DST suppressors, had a higher incidence of suicidal attempts and past and family history of depression, needed 
electroconvulsive therapy more often, but showed a better response to therapy. Though the claim of the DST 
being a specific biological marker for endogenous depression remains controversial, it is an useful investigative tool 
for the diagnosis and treatment of endogenous depression. 
Depression is one of the most frequent 
illness in psychiatric practice. However, due 
to disagreements about the nosological classi-
fication the diagnosis of depressive disorders 
remain confusing. The practical consequen-
ces of this diagnostic uncertainity are that 
some patients with endogenous depression do 
not receive effective somatic therapies, while 
patients with nonendogenous depression may 
be treated inappropriately. It is obvious that 
an objective laboratory test for the diagnosis 
of endogenous depression would be extremely 
useful. 
Hypothalamus-pituitary-adrenal (HPA) 
axis dysregulation in depression has been 
widely studied with the DST during the past 
few years. Some investigators have hailed 
the DST as a diagnostic test for endogenous 
depression (Carroll et al., 1981) though 
others have refuted these claims (Berger et al., 
1984). In view of the conflicting results the 
present study was undertaken to evaluate 
the DST in endogenous depression in an 
Indian setting. 
MATERIAL AND METHOD 
The sample consisted of 34 male inpa-
tients in a large service hospital with the 
diagnosis of Manic-depressive psychosis—De-
pressed type (ICD-9). Severity of depres-
sion was assessed by the Hamilton rating 
scale for depression (HRSD). Patients with 
a minimum HRSD score of 21 were only 
included in the study. Thirty healthy volun-
teers from staff members, matching closely 
in age with the patients, and screened 
thoroughly to exclude any psychiatric illness, 
constituted the control sample. All the sub-
jects were free of drugs known to interfere 
with the DST for atleast one month (Carroll, 
1983). There was no evidence of any phy-
sical illness, particularly pointing to endocri-
nopathy. Those with a history of alcoholism, 
drug addiction, excessive ingestion of coffee 
(more than 4 cups/day) or recent Weight 
loss were excluded. All subjects gave in-
formed consent. Details of past and family 
history were obtained from the patient, 
his relatives, if available, and records of 
previous hospitalisation. 
All patients were kept drug free for three 
days after hospitalisation while they were 
investigated and got acclimatised to the 
hospital milieu. On the fourth day, 1 mg of 
dexamethasone was administered orally at 
11 PM under observation of nursing staff. 
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Blood samples were collected at 4 PM & 11 
PM the next day for estimation of plasma 
Cortisol by radioimmunoassay. DST non-
suppression was defined as a post-dexame-
thasone plasma Cortisol (PDPC) level in 
any one sample, equal to or greater than 
5 jug/d\. The clinical investigators had no 
knowledge of the DST results till the dis-
charge of the patients. The laboratory tech-
nician estimating the plasma Cortisol level 
was unaware of the clinical details of the 
subjects. 
All patients were treated with imipramine 
hydrochloride (Dose range 150-225 mg/ 
day in divided doses). To start with they 
Were put on 75 mg of imipramine hydro-
chloride and the dose was gradually increased, 
depending on the clinical response. Severely 
depressed patients with active suicidal rumi-
nation, in addition to antidepressants, also 
received ECTs (4-6). Outcome of treatment 
was assessed by repeating the HRSD every 
7 days. Clinical recovery was defined as a 
HRSD score of 5 or less. Statistical analysis 
was performed using the students V test 
and Chi square test (with Yates correction 
where applicable). Predictive power of the 
DST were calculated as per Baldessarini 
etal. (1983). 
RESULTS 
DST nonsuppression occurred in 23 pati-
ents and 2 of the normal controls. Thus the 
DST had a sensitivity of 67.6%, a specificity 
of 93.3% and a positive predictive power of 
92% which compares favourably with other 
diagnostic tests in clinical medicine (Carroll, 
1982). Depressed patients did not differ 
significantly from the normal controls in 
respect of age. The mean score of the 
depressed patients on the HRSD was 28.4. 
The mean PDPC level of the patients was 
significantly higher than those of the controls 
both at 4 PM (5.51 figjdl versus 2.4 fig/dl) 
and 11 PM (3.84 /tg/dl versus 1.3 yUg/dl) 
(Table I). 
DST nonsuppressors and suppressors did 
not differ in respect of mean age. However, 
DST nonsuppressors as a group were signi-
ficantly more depressed compared to DST 
TABLE I. Clinical and laboratory characteristics of normal controls, depressed patients and DST nonsuppressors & suppressors 
Subjects 
Normal 
Controls* 
Depressed 
patients" 
DST non-suppressors
0 
DST 
suppressors'
1 
N 
30 
34 
23 
11 
Mean age 
in years 
(range) 
34.1** 
(19-48) 
34.7** 
(19-47) 
35.4** 
(19-47) 
33.3** 
(23-43) 
Mean HRSD 
score 
(±SD) 
2.2* 
(1.5) 
28.4* 
(4.69) 
29.7J 
(3.28) 
26.2J 
(3.33) 
Mean PDPC levels in 
/Ig/dl (±SD) at 
4 PM 
2.4* 
(1.4) 
5.51* 
(2.93) 
6.48J 
(2.05) 
3.4J 
(1.12) 
11 PM 
1.3* 
(0.8) 
3.84* 
(2.24) 
4.8| 
(1.23) 
1.8f 
(0.51) 
Note : While comparing a versus b and c versus d 
•indicates significance at 0.1% p<0.001 
•findicates significance at 1.0% p<0.01 
{indicates significance at 5% p<0.05% 
** indicates comparison not significantly different. 298  8. OHAUDHURY ET AL. 
suppressors (Table I) and had a higher inci-
dence of suicidal attempts (4 versus 1), past 
history of depression (6 versus 2) and family 
history of depressive illness (4 versus 0). 
Treatment with ECT, in addition to anti-
depressants, was required by 78.3% (n=18) 
of nonsuppressors as compared to 45.4% 
(n = 5) of suppressors. A satisfactory response 
to therapy was obtained in 82.6% (n=19) 
of nonsuppressors compared to 63.6% (n = 7) 
of suppressors. 
DISCUSSION 
The mean PDPC levels of the depressed 
patients was significantly higher as compared 
to the controls both at 4 PM and 11 PM. 
Moreover, the mean PDPC levels of the pa-
tients at 4 PM was higher than the levels at 
11 PM (Table I). These observations con-
firm the findings of Halbreich et al. (1985) 
and suggest that despite the plasma Cortisol 
hypersecretion, the circadian rhythm of 
plasma Cortisol secretion is maintained in the 
depressed patients. 
The high sensitivity of the DST for endo-
genous depression in the present study 
(67.6%), though in agreement with some 
reports (Carroll et al., 1981; Targum et al., 
1982), contrasts with the low sensitivity of 
25% & 30% reported by Meltzer et al. 
(1982) and Peselow et al. (1983), which could 
be due to variations in the DST procedure 
employed and inclusion of more patients with 
mild depression HRSD score > 16. 
In agreement with a number of studies 
(Carroll etal., 1981; Bowie & Beaini., 1985), 
in our study also the DST had a specificity of 
93.3% for endogenous depression. This ob-
servation, however, contrasts with the low 
specificity of 53% & 56% reported by 
Meltzer et al. (1982) and Berger et al. (1984) 
who concluded that the DST is not specific 
for endogenous depression and explained 
DST nonsuppression on the basis of con-
founding intervening variables such as the 
stress of hospitalisation, withdrawal of psy-
choactive drugs, weight loss, alcohol with-
drawal and so on. However, despite eliminat-
ing these factors, we found a higher speci-
ficity of the DST for endogenous depression. 
In the present study conducted at a gene-
ral psychiatric ward with a prevalence of 
53.1% of endogenous depression the DST 
had a positive predictive power of 92%, 
which is in agreement with a number of 
studies and proves the usefulness of the DST 
in the diagnosis of endogenous depression. 
However, the predictive power of the DST 
varies tremendously depending upon the 
prevalence, and can increase from 29% to 
92% with no change other than increased 
prevalence of endogenous depression (Sha-
piro & Lehman., 1983). Unless this is appre-
ciated, the performance of the DST can be 
very disappointing. The results of the DST 
can be improved by screening patients to 
increase artificially the prevalence of endo-
genous depression and improving specificity 
by controlling the factors known to produce 
false-positive results. Just as physicians do 
not use routine ECGs to screen for myocardial 
infarction, psychiatrists should not use the 
DST to screen psychiatric patients for endo-
genous depression. Thorough clinical assess-
ment must always precede any laboratory 
testing which is aimed at confirming a ten-
tative diagnosis. 
DST nonsuppressors Were significantly 
more depressed as compared to DST suppres-
sors (Table I), which is consistent with the 
findings of Whiteford et al. (1986) and also 
explains why DST nonsuppressors required 
treatment with ECT more often. The HPA 
disruption therefore appears to be explained 
by the severity of depression. On the other 
hand, Levy and Stern (1987) failed to find 
a significant relation between the severity 
of depression and DST nonsuppression. Thus 
further investigations are warranted. 
A strong association between suicidal 
behaviour and abnormal DST results has 
been observed and it has been suggested that DST IN DEPRESSIVES  299 
the tendency of endogenously depressed 
patients to attempt suicide is exacerbated 
by an underlying neurobiological disorder 
reflected by limbic HPA axis dysregulation 
(Carroll, 1982; Targum et al., 1983). In 
our study also, of the five patients who gave 
a history of suicidal behaviour four were DST 
nonsuppressors. 
A family history of depressive illness Was 
given by only four patients, but interestingly 
all were DST nonsuppressors. Though the 
number is small, this finding is consistent with 
the view that among patients with endogenous 
depression, abnormal DSTs are significantly 
associated with a family history of depression 
(Carroll, 1982). 
A pretreatment abnormal DST result 
appears to predict a favourable response to 
therapy, as is evident from the fact that 82.6% 
of nonsuppressors showed a good response 
to therapy, compared to 63.6% of suppre-
ssors. Likewise, Arana et al. (1985) after 
reviewing eight studies involving 819 patients 
concluded that 75.5% of DST nonsuppressors 
responded satisfactorily to treatment com-
pared to 64.4% of suppressors. 
DST nonsuppression is claimed to be a 
biological marker for endogenous depression 
comparable to serum acid phosphatase levels 
in prostatic carcinoma, implying that the 
cause of the abnormal test reflects the cause 
of the disease. This claim is premature be-
cause, as yet, there is no evidence for a pa-
thological process occurring in endogenous 
depression for which DST nonsuppression 
is a 'marker'. Attempts to explain nonsup-
pression as an indicator of cholinergic hypo-
activity or of noradrenergic hyperactivity in 
the hypothalamus remain speculative (Car-
roll, 1982). Current evidence indicate that 
these explanations are considerable over-
simplifications of the biochemical abnormality 
in endogenous depression. It is probable 
that the HPA axis hyperactivity is only a sign 
occurring in a subgroup of patients with 
endogenous depression. However, the ability 
of the DST to identify this abnormality ac-
curately makes the test useful in the diagnosis 
and management of patients having endo-
genous depression. 
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